Leading Justice is a full-service marketing company working with law firms on a cash-buy basis to sign up fully qualified, fraud-free JET 7 Xtra Flex Catheter-related injury cases. Here at Leading Justice, we can customize your firm’s JET 7 Xtra Flex Catheter advertising needs and help you sign up cases via internal cash buys. Our clients only pay an agency fee to cover the cost of JET 7 Xtra Flex Catheter advertising, plus a fee for each case we sign, and any data we generate for your firm belongs to you. We also cross-qualify all of our contacts, which means any data we generate that doesn’t qualify for the target campaign is evaluated to determine whether it qualifies for another type of claim. By using innovative approaches to target contacts specifically related to the JET 7 Xtra Flex Catheter and side effects like hemorrhage, vessel damage, arterial rupture and wrongful death, Leading Justice will increase your firm’s JET 7 Xtra Flex Catheter caseload. If you are interested in helping victims of JET 7 Xtra Flex Catheter side effects and complications, our direct advertising strategies and extensive consumer reach at Leading Justice gives you the competitive edge and confidence you need to allocate your full budget, knowing that your money is being spent in the best way possible.
Each law firm we work with at Leading Justice plays a critical role in determining how we categorize claims as qualified or not. And while our experience working with plaintiff law firms allows us to recognize a great case when we see one, we will tailor our JET 7 Xtra Flex Catheter intake specifications to the exact criteria you are seeking. So, if your firm has specific JET 7 Xtra Flex Catheter qualifying case criteria you want us to use, we can train our intake specialists to apply the criteria to each email and phone call they receive. By getting rid of the middle man, Leading Justice offers clients an opportunity for internal cash buys of JET 7 Xtra Flex Catheter injury data with no chance of fraud.
JET 7 Xtra Flex Catheter Litigation
Penumbra’s JET 7 Xtra Flex Catheter is an aspiration catheter commonly used during thrombectomy procedures to remove blood clots and restore blood flow in patients experiencing an acute ischemic stroke. An ischemic stroke occurs when the flow of blood through an artery in the brain is blocked by a blood clot, or a mass of thickened blood, also known as a thrombus. If left untreated, the clot can cut off the supply of blood to the brain and cause potentially life-threatening complications, such as stroke. A common treatment for the removal of dangerous blood clots in the brain is a thrombectomy. During this procedure, a catheter like Penumbra’s JET 7 Xtra Flex Catheter is inserted into the patient’s blood vessel to remove the blockage (the blood clot) and restore blood flow to the affected area. However, Penumbra has indicated that the JET 7 Xtra Flex Catheter “may become susceptible to distal tip damage during use,” which can result in “potential vessel damage, and subsequent patient injury or death.”
The FDA announced Penumbra’s urgent recall of more than 30,000 JET 7 Xtra Flex Catheters in December 2020, notifying healthcare providers that the use of the catheters during clot removal procedures is associated with an increased risk of mortality and serious injury. The recall was issued after the FDA received more than 200 medical device reports citing product malfunctions, serious injuries and patient deaths associated with the JET 7 Xtra Flex Catheter and JET 7MAX configuration, which includes the JET 7 Xtra Flex Catheter and MAX Delivery Device. According to the FDA recall notice, the distal tip of the recalled JET 7 Xtra Flex Catheters may break, fracture or expand during use, which can rupture the blood vessel while a clot is being removed from the brain and put patients at risk for serious and potentially life-threatening complications like hemorrhage, cerebral infarction (stroke) or wrongful death. Individuals who have suffered injuries or lost a loved one as a result of problems with Penumbra’s JET 7 Xtra Flex Catheter may be eligible to pursue compensation from Penumbra through a product liability lawsuit.